fereshteh fakour - Reproductive Health Research Center, Department of Obstetrics & Gynecology, Al-zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Roya KaboodMehri - Reproductive Health Research Center , Department of Obstetrics & Gynecology, Al-zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Amirhossein hajizadeh Fallah - Guilan University of Medical Sciences, Rasht, Iran
Maryam Dourandeesh - Eye Research Center, Department of Eye, Amiralmomenin Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Fatemeh Gholamalipour - Reproductive Health Research Center, Department of Obstetrics & Gynecology, Al-zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Seyedeh Maryam Attari - Reproductive Health Research Center, Al-zahra Hospital, Guilan University of Medical Sciences, Rasht, Iran
forozan Milani - Reproductive Health Research Center, Department of Obstetrics & Gynecology, Al-zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
zahra pourhabibi - Vice-Chancellorship of Research and Technology, Guilan University of Medical Science, Rasht

Background & Objective: Most pain relief methods are associated with some side effects and limitations. Magnesium sulfate, due to its osmotic properties and absorption of cervical water (moisture) can shorten labor duration and decrease labor pain via improving effacement and cervical edema. The aim of our study was to evaluate the effect of intravaginal magnesium sulfate on pain severity and duration of the first and second stages of labor. Materials & Methods: In this double-blind randomized clinical trial study, ۷۰ nulliparous women were allocated into two groups after the beginning of the active phase of labor. In group ۱, ۱۰ ccs of magnesium sulfate ۵۰% was poured on the whole cervix during the vaginal examination. In group ۲, a placebo (sterile water) in a similar way and amount was used. Then the two groups were compared in variables of demographic, obstetrics, clinical, pain severity, duration of the first and second stages of labor, and maternal and neonatal outcomes. Results: In different dilatations, pain severity in group ۱ was significantly lower (P=۰.۰۰۰۱). The duration of the first and second stages of labor was shorter in group ۱ (P =۰.۰۰۰۱). The two groups were similar in neonatal outcomes, drug side effects, and treatment satisfaction (P >۰.۰۵). Conclusion: Intravaginal magnesium sulfate improves the condition of the cervix, reduces the duration and the severity of labor pain, and has no medical or neonatal side effects.

magnesium sulfate, vaginal delivery, labor, Pain